Sfoglia per Autore
An unusual type of myeloid sarcoma localization following myelofibrosis : a case report and literature review
2017 N. Orofino, D. Cattaneo, C. Bucelli, L. Pettine, S. Fabris, U. Gianelli, N.S. Fracchiolla, A. Cortelezzi, A. Iurlo
Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications
2017 N.S. Fracchiolla, B. Fattizzo, A. Cortelezzi
Concomitant Occurrence of Blastic Plasmacytoid Dendritic Cell Neoplasm and Acute Myeloid Leukaemia after Lenalidomide Treatment for del(5q) Myelodysplastic Syndrome
2017 N.S. Fracchiolla, A. Iurlo, V. Ferla, B. Fattizzo, A. Freyrie, G. Reda, A. Cortelezzi
Secondary acute myeloid leukaemia in elderly patients : Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions : an analysis of 280 patients by the network rete ematologica lombarda (REL)
2018 E. Borlenghi, C. Pagani, P. Zappasodi, M. Bernardi, C. Basilico, E. Todisco, N. Fracchiolla, V. Mancini, M. Turrini, M. Da Vià, E. Sala, C. Cattaneo, M. Petullà, F. Serana, A. Ferrario, R. Cairoli, A. Cortelezzi, A. Santoro, C. Castagnola, G. Rossi
Severe hypofibrinogenemia associated with imatinib and prednisone therapy in Philadelphia chromosome–positive acute lymphoblastic leukemia
2018 M. Sciumè, N.S. Fracchiolla, A. Cortelezzi
Molecular remission at the end of treatment is a necessary goal for a good outcome in ELN favorable-risk acute myeloid leukemia: a real-life analysis on 201 patients by the Rete Ematologica Lombarda network
2018 P. Zappasodi, L. Marbello, E. Borlenghi, M. Fumagalli, M. Bernardi, N. Fracchiolla, V. Mancini, M. Da Via, E. Ravano, E. Cerqui, V.V. Ferretti, B. Rocca, C. Calvello, M. Cazzola, C. Castagnola, G. Rossi
The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects
2020 B. Fattizzo, J. Rosa, J.A. Giannotta, L. Baldini, N.S. Fracchiolla
Reply to “COVID-19 in persons with haematological cancers”: a focus on myeloid neoplasms and risk factors for mortality
2020 B. Fattizzo, J.A. Giannotta, M. Sciume, D. Cattaneo, C. Bucelli, N.S. Fracchiolla, F. Onida, L. Baldini, W. Barcellini, A. Iurlo
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy)
2020 B. Fattizzo, J.A. Giannotta, W. Barcellini, M.C. Barbanti, C. Bucelli, R. Cassin, D. Cattaneo, F. Cavallaro, V. Ferla, N.S. Fracchiolla, A. Freyrie, G. Galassi, M.C. Goldaniga, F.I. Grifoni, A. Iurlo, G. Mangiameli, V. Mattiello, M. Meli, A. Neri, A. Noto, F. Onida, L. Ottani, R. Pasquale, L. Pettine, A. Pompa, G. Reda, F.G. Rossi, G.N. Saporiti, M. Sciumè, E. Tagliaferri, L. Baldini
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913
2021 S. Chiaretti, M. Messina, I.D. Starza, A. Piciocchi, L. Cafforio, M. Cavalli, A. Taherinasab, M. Ansuinelli, L. Elia, G.A. Petroni, R. la Starza, M. Canichella, A. Lauretti, M.C. Puzzolo, V. Pierini, A. Santoro, O. Spinelli, V. Apicella, S. Capria, F. Di Raimondo, P. de Fabritiis, C. Papayannidis, A. Candoni, R. Cairoli, M. Cerrano, N. Fracchiolla, D. Mattei, C. Cattaneo, A. Vitale, E. Crea, P. Fazi, C. Mecucci, A. Rambaldi, A. Guarini, R. Bassan, R. Foa
Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy
2021 E. Saccon, A. Bandera, M. Sciumè, F. Mikaeloff, A.A. Lashari, S. Aliberti, M.C. Sachs, F. Billi, F. Blasi, E.E. Gabriel, G. Costantino, P. De Roberto, S. Krishnan, A. Gori, F. Peyvandi, L. Scudeller, C. Canetta, C.L. Lorson, L. Valenti, K. Singh, L. Baldini, N.S. Fracchiolla, U. Neogi
Secondary infections worsen the outcome of COVID-19 in patients with hematological malignancies: A report from the ITA-HEMA-COV
2022 P. Zappasodi, C. Cattaneo, V. Valeria Ferretti, R. Mina, A. José María Ferreri, F. Merli, M. Oberti, M. Krampera, A. Romano, C. Zerbi, J. Ferrari, M. Cavo, M. Salvini, L. Bertù, N. Stefano Fracchiolla, F. Marchesi, M. Massaia, V. Marasco, R. Cairoli, A. Maria Scattolin, A. Maria Vannucchi, C. Gambacorti-Passerini, P. Musto, F. Gherlinzoni, A. Cuneo, A. Pinto, L. Trentin, M. Bocchia, S. Galimberti, E. Coviello, M. Chiara Tisi, A. Morotti, B. Falini, M. Turrini, A. Tafuri, A. Billio, M. Gentile, R. Massimo Lemoli, A. Venditti, M. Giovanni Della Porta, F. Lanza, L. Rigacci, P. Tosi, S. Mohamed, A. Corso, M. Luppi, N. Giuliani, A. Busca, L. Pagano, R. Bruno, P. Antonio Grossi, P. Corradini, F. Passamonti, L. Arcaini
Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry
2023 J. Salmanton-García, F. Marchesi, M. Gomes da Silva, F. Farina, J. Dávila-Valls, Y.M. Bilgin, A. Glenthøj, I. Falces-Romero, J. Van Doesum, J. Labrador, C. Buquicchio, S. El-Ashwah, V. Petzer, J. Van Praet, M. Schönlein, M. Dargenio, G. Méndez, S. Meers, F. Itri, A. Giordano, L.I. Pinczés, I. Espigado, Z. Stojanoski, A. López-García, L. Prezioso, O. Jaksic, A. Vena, N.S. Fracchiolla, T.J. González-López, N. Colović, M. Delia, B. Weinbergerová, M. Marchetti, J. Marques de Almeida, O. Finizio, C. Besson, M.M. Biernat, T. Valković, T. Lahmer, A. Cuccaro, I. Ormazabal-Vélez, J. Batinić, N. Fernández, N. De Jonge, C. Tascini, A.N. Anastasopoulou, R. Duléry, M.I. Del Principe, G. Plantefeve, M.V. Papa, M. Nucci, M. Jiménez, A. Aujayeb, J. Hernández-Rivas, M. Merelli, C. Cattaneo, O. Blennow, A. Nordlander, A. Cabirta, G. Varricchio, M.V. Sacchi, R. Cordoba, E. Arellano, S.K. Gräfe, D. Wolf, Z. Emarah, E. Ammatuna, D.S. Hersby, S. Martín-Pérez, R. Nunes Rodrigues, L. Rahimli, L. Pagano, O.A. Cornely
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile